Immunotherapy as an adjunct to surgery in the treatment of cancer
- PMID: 602232
- DOI: 10.1007/BF01556179
Immunotherapy as an adjunct to surgery in the treatment of cancer
Similar articles
-
Immunotherapy of cancer.Ariz Med. 1977 Jun;34(6):396-8. Ariz Med. 1977. PMID: 880051 No abstract available.
-
Immunotherapy of cancer: current status.Prog Exp Tumor Res. 1980;25:61-88. doi: 10.1159/000403177. Prog Exp Tumor Res. 1980. PMID: 6986637 Review. No abstract available.
-
Introduction: Immunotherapy of cancer in man, a reality.Natl Cancer Inst Monogr. 1973 Dec;39:139-61. Natl Cancer Inst Monogr. 1973. PMID: 4206961 No abstract available.
-
Clinical trials of immunotherapy: present status.Cancer. 1978 Nov;42(5):2224-33. doi: 10.1002/1097-0142(197811)42:5<2224::aid-cncr2820420521>3.0.co;2-f. Cancer. 1978. PMID: 363256 Review.
-
Immunotherapy from malignant disease.Annu Rev Med. 1978;29:231-83. doi: 10.1146/annurev.me.29.020178.001311. Annu Rev Med. 1978. PMID: 348035 Review. No abstract available.
Cited by
-
Polymer-loaded hydrogels serve as depots for lactate and mimic "cold" tumor microenvironments.Biomater Sci. 2020 Nov 7;8(21):6056-6068. doi: 10.1039/d0bm01196g. Epub 2020 Oct 1. Biomater Sci. 2020. PMID: 33000781 Free PMC article.
-
Hemangiopericytoma: a clinicopathologic and ultrastructure study.World J Surg. 1981 Nov;5(6):863-71. doi: 10.1007/BF01657977. World J Surg. 1981. PMID: 7342484 No abstract available.